These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33124144)

  • 21. Impact of CD4 T cell count on the outcome of planned treatment interruptions in early-treated human immunodeficiency virus-infected children.
    Fortuny C; Noguera-Julian A; Alsina L; Bellido R; Sánchez E; Muñoz-Almagro C; Ruiz L; Jiménez R
    Pediatr Infect Dis J; 2011 May; 30(5):435-8. PubMed ID: 21030884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).
    Joly V; Fagard C; Grondin C; Descamps D; Yazdanpanah Y; Charpentier C; Colin de Verdiere N; Tabuteau S; Raffi F; Cabie A; Chene G; Yeni P;
    Antimicrob Agents Chemother; 2013 Feb; 57(2):758-65. PubMed ID: 23165467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.
    Harrison L; Ananworanich J; Hamadache D; Compagnucci A; Penazzato M; Bunupuradah T; Mazza A; Ramos JT; Flynn J; Rampon O; Mellado Pena MJ; Floret D; Marczynska M; Puga A; Forcat S; Riault Y; Lallemant M; Castro H; Gibb DM; Giaquinto C;
    AIDS Behav; 2013 Jan; 17(1):193-202. PubMed ID: 22584916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.
    Davies MA; Boulle A; Technau K; Eley B; Moultrie H; Rabie H; Garone D; Giddy J; Wood R; Egger M; Keiser O;
    Trop Med Int Health; 2012 Nov; 17(11):1386-90. PubMed ID: 22974345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China.
    Zheng J; Zhao D
    BMC Res Notes; 2014 Jul; 7():419. PubMed ID: 24994004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.
    Chereau F; Madec Y; Sabin C; Obel N; Ruiz-Mateos E; Chrysos G; Fidler S; Lehmann C; Zangerle R; Wittkop L; Reiss P; Hamouda O; Estrada Perez V; Leal M; Mocroft A; Garcia De Olalla P; Ammassari A; D'Arminio Monforte A; Mussini C; Segura F; Castagna A; Cavassini M; Grabar S; Morlat P; De Wit S; Lambotte O; Meyer L;
    PLoS One; 2017; 12(4):e0173893. PubMed ID: 28380038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Immunological and Virological Outcomes in Children Receiving Highly Active Antiretroviral Therapy at Hawassa University College of Medicine and Health Sciences, Southern Ethiopia.
    Fenta DA; Wube TB; Nuru MM
    J Immunol Res; 2021; 2021():2498025. PubMed ID: 33928167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological and Virological Responses to Highly Active Antiretroviral Therapy in HIV-1 Infected Children.
    Singh R; Mukherjee A; Singla M; Das BK; Kabra SK; Lodha R
    Indian J Pediatr; 2017 Dec; 84(12):893-896. PubMed ID: 28875475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
    AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
    Nemes E; Lugli E; Nasi M; Ferraresi R; Pinti M; Bugarini R; Borghi V; Prati F; Esposito R; Cossarizza A; Mussini C
    AIDS; 2006 Oct; 20(16):2021-32. PubMed ID: 17053348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART.
    Ceccherini-Silberstein F; Cozzi Lepri A; Alteri C; Merlini E; Surdo M; Marchetti G; Capobianchi MR; De Luca A; Gianotti N; Viale P; Andreoni M; Antinori A; Perno CF; d'Arminio Monforte A;
    J Antimicrob Chemother; 2018 Dec; 73(12):3460-3470. PubMed ID: 30247724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.
    Gras L; May M; Ryder LP; Trickey A; Helleberg M; Obel N; Thiebaut R; Guest J; Gill J; Crane H; Dias Lima V; dʼArminio Monforte A; Sterling TR; Miro J; Moreno S; Stephan C; Smith C; Tate J; Shepherd L; Saag M; Rieger A; Gillor D; Cavassini M; Montero M; Ingle SM; Reiss P; Costagliola D; Wit FWNM; Sterne J; de Wolf F; Geskus R;
    J Acquir Immune Defic Syndr; 2019 Mar; 80(3):292-300. PubMed ID: 30531492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.
    Mermin J; Ekwaru JP; Were W; Degerman R; Bunnell R; Kaharuza F; Downing R; Coutinho A; Solberg P; Alexander LN; Tappero J; Campbell J; Moore DM
    BMJ; 2011 Nov; 343():d6792. PubMed ID: 22074711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial.
    Goujard C; Emilie D; Roussillon C; Godot V; Rouzioux C; Venet A; Colin C; Pialoux G; Girard PM; Boilet V; Chaix ML; Galanaud P; Chene G;
    AIDS; 2012 Sep; 26(15):1895-905. PubMed ID: 22842994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
    ARROW Trial team
    Lancet; 2013 Apr; 381(9875):1391-1403. PubMed ID: 23473847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success.
    Alteri C; Scutari R; Stingone C; Maffongelli G; Brugneti M; Falasca F; Martini S; Bertoli A; Turriziani O; Sarmati L; Coppola N; Andreoni M; Santoro MM; Perno CF; Ceccherini-Silberstein F; Svicher V
    J Clin Virol; 2019 Aug; 117():61-67. PubMed ID: 31229934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of suboptimal CD4
    Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
    J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.